Akademik Veri Yönetim Sistemi
The American journal of emergency medicine, cilt.29, 2011 (SCI-Expanded)
Terlipressin is a longer half-life synthetic analogue of vasopressin. Its use is approved in esophageal variceal bleedings as an adjuvant therapy. The beneficial effects of terlipressin use in children with septic shock had also been revealed. We described a 10-month-old boy with massive, life-threatening, nonvariceal upper gastrointestinal bleeding rescued with terlipressin therapy. To our knowledge, this is the first report of terlipressin use in a child with nonvariceal upper gastrointestinal bleeding. It might be useful as rescue therapy in refractory cases of nonvariceal upper gastrointestinal bleeding when surgery or endoscopic procedures could not be performed.